131 Coupled CAR® technology strengthens adoptive T cell therapy by promoting rapid expansion

Affiliations

Xi Huang: The First Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
Zhiyuan Cao: Innovative Cellular Therapeutics, Shanghai, China
Chengfei Pu: Innovative Cellular Therapeutics, Shanghai, China
Xianyang Jiang: Innovative Cellular Therapeutics, Shanghai, China
Xiaogang Shen: Innovative Cellular Therapeutics, Shanghai, China
Ruihong Zhu: Innovative Cellular Therapeutics, Shanghai, China
Yuzhe Peng: Innovative Cellular Therapeutics, Shanghai, China
Zhao Wu: Innovative Cellular Therapeutics, Shanghai, China
Lei Xiao: Innovative Cellular Therapeutics, Shanghai, China

Abstract

No abstracts available.

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com